ISSN 0975-3583
 

Journal of Cardiovascular Disease Research



    Assessment of cardiac functions using two-dimensional transthoracic and speckle tracking echocardiography after treatment with SGLT2 inhibitors in Patients with HFrEF


    Amr Setouhi, Ashraf Radi, Hany Taha Asklany, Hazem MA Farrag
    JCDR. 2023: 1532-1546

    Abstract

    Recently, the antidiabetic drug sodium-glucose cotransporter type 2 inhibitor (SGLT2i) has been approved among the drugs that reduce mortality in patients with Heart failure with reduced ejection fraction (HFrEF). The impact of SGLT2i inhibitors on the left ventricle longitudinal myocardial function in heart failure (HF) patients remained vague. The effect of SGLT2i on left ventricular remodeling and function in patients with HFrEF was studied using speckle tracking (STE) and traditional echocardiography

    Description

    » PDF

    Volume & Issue

    Volume 14 Issue 6

    Keywords